QUCYMainz Biomed N.V. Ordinary Shares

NAS · US · Healthcare · Diagnostics & Research · quantum-cyber.ai

1.300USDMkt Cap: 109.29M $P/E: —3d ago

Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust arc…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap109.29M $

Enterprise Value17.34M $

Revenue (TTM)537.08K $

Gross Profit389.79K $

Net Income (TTM)-16.21M $

Revenue/Share0.0660 USD

Last Price1.300 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees10

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-1.36

EV/Revenue32.28

P/S212.88

P/B3.74

EPS (TTM)-2.41

EPS (Forward)—

52W Range

1.27033% of range1.360

52W High1.360 USD

52W Low1.270 USD

Profitability

Gross Margin72.58%

Oper. Margin-2460.78%

EBITDA Margin0.00%

Profit Margin-3018.31%

ROE-2526.61%

ROA-304.29%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-10.98M $

CapEx (TTM)1.05M $

FCF Margin-1632.60%

FCF Yield-8.02%

Net Debt-4.32M $

Net Debt/EBITDA0.34

Balance Sheet

Debt/Equity4.01

Current Ratio2.11

Quick Ratio1.42

Book Value/Sh0.3640 USD

Cash/Share0.3040 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.0 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)9.000 USD

Upside (mean)+592.3%

Target Range9.000 USD – 9.000 USD

# Analysts1

Ownership

Shares Out.84.07M

Float4.25M

Insiders249.22%

Institutions1.01%

Short Interest

Short Ratio3.0d

Short % Float11.62%

Short % Out.11.26%

Shares Short2.56M

Short (prev mo.)3.37M

Technical

SMA 501.432 (-9.2%)

SMA 2001.190 (+9.2%)

Beta2.32

S&P 52W Chg21.00%

Avg Vol (30d)1.04M

Avg Vol (10d)788.14K

Technical Indicators

RSI (14)45.7

MACD0.0072

MACD Signal-0.0033

MACD Hist.+0.0105

BB Upper1.618 USD

BB Middle1.325 USD

BB Lower1.031 USD

BB Width44.28%

ATR (14)0.1389 USD

Vol Ratio (20d)1.35x